LIVING CURES
LIVING CURES
LIVING CURES
[Re]engineering evolution into Living Cures platform for novel immunotherapies
[Re]engineering evolution into Living Cures platform for novel immunotherapies
[Re]engineering evolution into Living Cures platform for novel immunotherapies
FOUNDATIONAL TECHNOLOGY
Prokarium's Foundational technology leverages inherent anti-tumor mechanisms of a proprietary strain of bacteria (ZH9) as a microbial immunotherapy platform
• Naturally tumor targeting and oncolytic
• Overcomes the suppressive tumor microenvironment
• Targets multiple pathways to elicit strong anti-tumor immunity
• Extensive opportunities to deliver diverse cargo
Proprietary ZH9 Chassis Strain
FOUNDATIONAL TECHNOLOGY
Prokarium's Foundational technology leverages inherent anti-tumor mechanisms of a proprietary strain of bacteria (ZH9) as a microbial immunotherapy platform
• Naturally tumor targeting and oncolytic
• Overcomes the suppressive tumor microenvironment
• Targets multiple pathways to elicit strong anti-tumor immunity
• Extensive opportunities to deliver diverse cargo
Proprietary ZH9 Chassis Strain
MARKET
MARKET
APPLICATIONS
APPLICATIONS
ABOUT US
TEAM
BOARD OF DIRECTORS
ADVISORS
Ibs Mahmood
CEO
Livija Deban, PhD
CSO
Dara Henry, PhD
COO
Josi Holz, MD, PhD
CMO
Julia Jones, FCA
CFO
Nick Glanville, PhD
VP of Research
TEAM
BOARD OF DIRECTORS
ADVISORS
Ibs Mahmood
CEO
Livija Deban, PhD
CSO
Dara Henry, PhD
COO
Josi Holz, MD, PhD
CMO
Julia Jones, FCA
CFO
Nick Glanville, PhD
VP of Research
PIPELINE
Indication
Discovery
Discovery
Preclinical
Preclinical
IND-Enabling
IND-Enabling
Phase I
ZH9 - Bladder cancer Non-muscle invasive
Phase I initiated in US
Indication
ZH9 - Bladder cancer Non-muscle invasive
Phase I initiated in US
ZH9 - Bladder cancer Muscle invasive
Combination with checkpoint inhibitors
Indication
ZH9 - Bladder cancer Muscle invasive
Combination with checkpoint inhibitors
IO Prime
First-in-class oral immune fitness agent ready to enter the clinic
Indication
IO Prime
First-in-class oral immune fitness agent ready to enter the clinic
Living Cures Platform
Discovery cargo-delivery IO platform
Indication
Living Cures Platform
Discovery cargo-delivery IO platform
NEWS
NEWS
EVENTS & PRESENTATIONS
8 May
2026
Prokarium to present at the American Urology Association (AUA) Annual Meeting
London, UK
Dr Michael Oefelein will be presenting on behalf of Prokarium at the American Urology Association (AUA) Annual Meeting,...
Read More
26 Apr
2026
Prokarium to present at LSX World Congress
London, UK
Kristen Albright, Prokarium’s CEO, will be presenting at the LSX World Congress event on 30th April in London.
Read More
18 Mar
2026
Prokarium presents data at EAU 2026
London, UK
Presentation
Prokarium’s CEO, Ibraheem Mahmood, presented interim data at this year’s European Association of Urology conference in London.
Read More
17 Mar
2026
Prokarium to attend BIO-Europe Spring 2026
London, UK
Prokarium’s COO, Dara Henry, will be attending BIO-Europe Spring in Lisbon, Portugal, 23-25th March 2026.
Read More
EVENTS & PRESENTATIONS
CAREERS
Design the future with us
Design the future with us
Design the future with us
Prokarium 2026 © All Rights Reserved
Prokarium 2026 © All Rights Reserved
Prokarium 2026 © All Rights Reserved